Granules India Promoters Inject ₹1,096 Crore Via Conversion of 2.49 Crore Warrants
Granules India allotted 2.49 crore equity shares to promoter group members upon warrant conversion, involving a balance payment of ₹1,096.13 crore on October 23.
ALFA News
Straight from the exchange filing
Every announcement Granules India has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Every Granules India announcement on ALFA FilingsSee filings →Reference market data from a third-party provider, as of the most recent story. Not a valuation or a recommendation.
Granules India allotted 2.49 crore equity shares to promoter group members upon warrant conversion, involving a balance payment of ₹1,096.13 crore on October 23.
Promoter Uma Devi Chigurupati acquired 2.48 crore shares of Granules India via the open market, raising her stake to 12.51%. Read more on this transaction here.
Granules India secures Sole First-to-File ANDA status for Sodium Oxybate ER, the generic equivalent of LUMRYZ, targeting the US narcolepsy treatment market.